| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | - | - | - | - | 2.356 | 3.007 | 4.473 | 28.377 | 9.487 |
| Total Income - EUR | - | - | - | - | - | 2.381 | 2.998 | 4.473 | 28.377 | 9.487 |
| Total Expenses - EUR | - | - | - | - | - | 7.528 | 5.401 | 2.181 | 28.366 | 19.714 |
| Gross Profit/Loss - EUR | - | - | - | - | - | -5.147 | -2.403 | 2.292 | 12 | -10.227 |
| Net Profit/Loss - EUR | - | - | - | - | - | -5.196 | -2.493 | 2.157 | 12 | -10.227 |
| Employees | - | - | - | - | - | 0 | 0 | 0 | 0 | 1 |
Check the financial reports for the company - Dr. Paw S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | - | - | - | - | 0 | 0 | 441 | 301 | 164 |
| Current Assets | - | - | - | - | - | 5.855 | 6.145 | 8.509 | 36.515 | 29.672 |
| Inventories | - | - | - | - | - | 1.275 | 1.465 | 1.469 | 1.465 | 1.240 |
| Receivables | - | - | - | - | - | 3.336 | 4.398 | 4.012 | 34.148 | 27.254 |
| Cash | - | - | - | - | - | 1.244 | 282 | 3.027 | 902 | 1.178 |
| Shareholders Funds | - | - | - | - | - | -3.129 | -6.197 | -4.059 | -4.035 | -14.239 |
| Social Capital | - | - | - | - | - | 2.067 | 2.022 | 2.028 | 2.022 | 2.010 |
| Debts | - | - | - | - | - | 8.984 | 12.342 | 13.009 | 40.851 | 44.075 |
| Income in Advance | - | - | - | - | - | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "4791 - 4791" | |||||||||
| CAEN Financial Year |
4791
|
|||||||||
Comments - Dr. Paw S.r.l.